📖 Crown Point Research – Social Market Update
Stock: T. Rowe Price (NASDAQ: TROW)
Date: 4th September 2025
Time: 09:10 PM IST
🔹 Fundamental News
Goldman Sachs commitment: Up to $1B equity purchase in T. Rowe Price → a rare institutional backing headline.
This triggered a 7%+ intraday surge, before settling lower.
Broader U.S. market moved on jobs data and tech resistance levels.
🔹 Public Sentiment & Human Behaviour
Retail: Chased the initial breakout above $116, buying late into the spike.
Institutions: Entered early, now letting pullbacks rebalance before next leg.
“T. Rowe rockets on Goldman deal” — but Crown Point notes this was a retest of an upper ceiling, not a breakout.
🔹 Current Structure
Macro View
Support: $104–106
Resistance: $118–120
Structure: Growth → Maturity stage. Controlled pullback after institutional spike.
Micro View
Support: $110–111
Resistance: $114–115
Behaviour: Intraday pullbacks forming, rebalancing after the surge.
🔹 Projection
Primary Path (65%): Hold $110–111 base → retest $114–115.
Alternate Path (25%): If $110 breaks, drift toward $104–106 macro
Low Path (10%): A fresh breakout above $120 requires extraordinary momentum or further institutional buying.
🔹 Pullback Levels
Shallow: $111–112
Medium: $110
Deep: $104–106
🔹 Final View
Bias (Macro): Bullish, as long as $104 holds. Swing path open toward $118–120.
Bias (Micro): Short-term consolidation between $110–115; pullbacks are opportunities, not reversals.
🔹 Essence (Philosophy Line)
“Macro shows a top at 120 and a bottom at 104. Micro waves are rebalancing between 110 and 115. In structure, pullbacks are gates to re-entry, not collapse — unless the sea gives way.”
⚠️ Disclaimer
“This analysis is shared for educational and research purposes only. It is not financial advice, trading advice, or investment recommendation. Market decisions are entirely your own responsibility.”
Stock: T. Rowe Price (NASDAQ: TROW)
Date: 4th September 2025
Time: 09:10 PM IST
🔹 Fundamental News
Goldman Sachs commitment: Up to $1B equity purchase in T. Rowe Price → a rare institutional backing headline.
This triggered a 7%+ intraday surge, before settling lower.
Broader U.S. market moved on jobs data and tech resistance levels.
🔹 Public Sentiment & Human Behaviour
Retail: Chased the initial breakout above $116, buying late into the spike.
Institutions: Entered early, now letting pullbacks rebalance before next leg.
“T. Rowe rockets on Goldman deal” — but Crown Point notes this was a retest of an upper ceiling, not a breakout.
🔹 Current Structure
Macro View
Support: $104–106
Resistance: $118–120
Structure: Growth → Maturity stage. Controlled pullback after institutional spike.
Micro View
Support: $110–111
Resistance: $114–115
Behaviour: Intraday pullbacks forming, rebalancing after the surge.
🔹 Projection
Primary Path (65%): Hold $110–111 base → retest $114–115.
Alternate Path (25%): If $110 breaks, drift toward $104–106 macro
Low Path (10%): A fresh breakout above $120 requires extraordinary momentum or further institutional buying.
🔹 Pullback Levels
Shallow: $111–112
Medium: $110
Deep: $104–106
🔹 Final View
Bias (Macro): Bullish, as long as $104 holds. Swing path open toward $118–120.
Bias (Micro): Short-term consolidation between $110–115; pullbacks are opportunities, not reversals.
🔹 Essence (Philosophy Line)
“Macro shows a top at 120 and a bottom at 104. Micro waves are rebalancing between 110 and 115. In structure, pullbacks are gates to re-entry, not collapse — unless the sea gives way.”
⚠️ Disclaimer
“This analysis is shared for educational and research purposes only. It is not financial advice, trading advice, or investment recommendation. Market decisions are entirely your own responsibility.”
Turning Chaos Into Structure !!!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Turning Chaos Into Structure !!!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.